1. Home
  2. IKT vs MPTI Comparison

IKT vs MPTI Comparison

Compare IKT & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • MPTI
  • Stock Information
  • Founded
  • IKT 2008
  • MPTI 1965
  • Country
  • IKT United States
  • MPTI United States
  • Employees
  • IKT N/A
  • MPTI N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • MPTI
  • Sector
  • IKT Health Care
  • MPTI
  • Exchange
  • IKT Nasdaq
  • MPTI Nasdaq
  • Market Cap
  • IKT 140.5M
  • MPTI 122.5M
  • IPO Year
  • IKT 2020
  • MPTI N/A
  • Fundamental
  • Price
  • IKT $1.85
  • MPTI $39.27
  • Analyst Decision
  • IKT Buy
  • MPTI
  • Analyst Count
  • IKT 2
  • MPTI 0
  • Target Price
  • IKT $8.00
  • MPTI N/A
  • AVG Volume (30 Days)
  • IKT 526.2K
  • MPTI 91.0K
  • Earning Date
  • IKT 08-13-2025
  • MPTI 08-13-2025
  • Dividend Yield
  • IKT N/A
  • MPTI N/A
  • EPS Growth
  • IKT N/A
  • MPTI 66.11
  • EPS
  • IKT N/A
  • MPTI 2.67
  • Revenue
  • IKT N/A
  • MPTI $50,559,000.00
  • Revenue This Year
  • IKT N/A
  • MPTI $11.76
  • Revenue Next Year
  • IKT N/A
  • MPTI $7.64
  • P/E Ratio
  • IKT N/A
  • MPTI $14.62
  • Revenue Growth
  • IKT N/A
  • MPTI 17.62
  • 52 Week Low
  • IKT $1.12
  • MPTI $23.93
  • 52 Week High
  • IKT $4.20
  • MPTI $60.00
  • Technical
  • Relative Strength Index (RSI)
  • IKT 47.71
  • MPTI 38.22
  • Support Level
  • IKT $1.80
  • MPTI $39.84
  • Resistance Level
  • IKT $2.09
  • MPTI $42.00
  • Average True Range (ATR)
  • IKT 0.14
  • MPTI 1.95
  • MACD
  • IKT 0.03
  • MPTI 0.13
  • Stochastic Oscillator
  • IKT 54.72
  • MPTI 45.19

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

Share on Social Networks: